Perrigo Company is an Irish–registered manufacturer of private label over-the-counter pharmaceuticals. Perrigo engages in the acquisition (for repricing), manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States. The company was founded in 1887 in Allegan, Michigan, by Luther and Charles Perrigo.
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential
Perrigo Company news
11.05.2022
Perrigo Company's GAAP loss for 3 months of 2022 was $2.4 million, compared to a loss of $38.1 million in the previous year. Revenue increased 6.4% to $1.075 billion from $1.01 billion a year earlier.
Source: 
investor.perrigo.com
investor.perrigo.com
05.05.2022
The Perrigo Company Board of Directors announced a quarterly dividend of $0.26 per share. The last day to buy securities to receive the dividend is June 1, 2022. The annual dividend yield may reach 2.65%.
Source: investor.perrigo.com
investor.perrigo.com
02.05.2022
Perrigo Company completed its €1.8 billion acquisition of HRA Pharma, a health care products company. The deal will allow Perrigo to increase revenues and EPS for fiscal year 2023 by €400 million and $1, respectively.
Source: investor.perrigo.com
investor.perrigo.com
01.03.2022
Perrigo Company's GAAP loss for 2021 was $68.9 million, down 2.4 times from $162.6 million in the previous year. Revenue increased 1.2% to $4.139 billion from $4.088 billion a year earlier.
Source: investor.perrigo.com
investor.perrigo.com
General information
| Company name | Perrigo Company |
|---|---|
| Tags | #pharmacy |
| Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals |
| Business address | TREASURY BUILDING LOWER GRAND CANAL STREET DUBLIN L2 L2 2 269-673-8451 |
| Mailing address | 515 EASTERN AVENUE ALLEGAN MI 49010 |
| Website | www.perrigo.com |
| Information disclosure | www.sec.gov |
English (US) 